Literature DB >> 6360891

Molecular analysis of immunoglobulins M and G immune response to protein antigens of Treponema pallidum in human syphilis.

M Moskophidis, F Müller.   

Abstract

Protein antigens of Treponema pallidum precipitated by immunoglobulin M (IgM) and IgG antibodies of sera from patients with untreated primary and secondary syphilis as well as treated secondary syphilis were characterized on a molecular basis. T. pallidum was labeled internally with [35S]methionine and solubilized in 0.1% sodium dodecyl sulfate-1% Triton X-100. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis on 12.5% gels followed by autoradiography revealed 32 distinct proteins with molecular weights between 13,500 and 200,000. Twenty-three proteins of T. pallidum with molecular weights between 15,500 and 115,000 were identified as antigens by double antibody radioimmunoprecipitation with IgM and IgG antibodies of sera from syphilitic patients. The molecular analysis of the IgM and IgG immune response to T. pallidum in human syphilis is in accord with earlier immunological observations. Finally, utilizing syphilitic human sera, we characterized 15 protein antigens of T. pallidum that are common to Treponema phagedenis by partial absorption of IgM and IgG antibodies with an ultrasonicate of T. phagedenis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6360891      PMCID: PMC263398          DOI: 10.1128/iai.43.1.127-132.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  IgM class antitreponemal antibody in treated and untreated syphilis.

Authors:  P O'Neill; C S Nicol
Journal:  Br J Vener Dis       Date:  1972-12

3.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

4.  Molecular characterization of common treponemal antigens.

Authors:  P A Hanff; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

Review 5.  [The 19S(IgM)-FTA-ABS test in the serodiagnosis of syphilis. Technique, sources of error and diagnostical information of results (author's transl)].

Authors:  F Müller
Journal:  Immun Infekt       Date:  1982-01

6.  Antibodies in secondary syphilis against five of forty Reiter treponeme antigens.

Authors:  N S Pedersen; N H Axelsen; B B Jørgensen; C S Petersen
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

7.  Fluorescent treponemal antibodies in fractionated syphilitic sera. The immunoglobulin class.

Authors:  W G Atwood; J L Miller
Journal:  Arch Dermatol       Date:  1969-12

8.  Parasitism by virulent Treponema pallidum of host cell surfaces.

Authors:  N S Hayes; K E Muse; A M Collier; J B Baseman
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

9.  Identification of Treponema pallidum antigens: comparison with a nonpathogenic treponeme.

Authors:  S A Lukehart; S A Baker-Zander; E R Gubish
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

10.  Surface characterization of virulent Treponema pallidum.

Authors:  J F Alderete; J B Baseman
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

View more
  28 in total

Review 1.  The endemic treponematoses.

Authors:  Lorenzo Giacani; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

2.  A new attempt to distinguish serologically the subspecies of Treponema pallidum causing syphilis and yaws.

Authors:  G T Noordhoek; A Cockayne; L M Schouls; R H Meloen; E Stolz; J D van Embden
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

3.  The inaccessibility of the outer membrane of adherent Treponema pallidum (Nichols strain) to anti-treponemal antibodies, a possible role of serum proteins.

Authors:  J J van der Sluis; M Kant; P C Onvlee; E Stolz
Journal:  Genitourin Med       Date:  1990-06

4.  Purification and characterization of a cloned protease-resistant Treponema pallidum-specific antigen.

Authors:  T E Fehniger; A M Walfield; T M Cunningham; J D Radolf; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

5.  Evaluation of an enzyme immunoassay for IgM antibodies to Treponema pallidum in syphilis in man.

Authors:  F Müller; M Moskophidis
Journal:  Br J Vener Dis       Date:  1984-10

6.  Antigenic cross-reactivity between Treponema pallidum and other pathogenic members of the family Spirochaetaceae.

Authors:  S A Baker-Zander; S A Lukehart
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

7.  Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness.

Authors:  J E Craft; D K Fischer; G T Shimamoto; A C Steere
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

8.  Immunoglobulin G subclasses of fluorescent anti-Treponema pallidum antibodies: evidence for sequential development of specific anti-T. pallidum immunoglobulin G responses in patients with early syphilis.

Authors:  J J van der Sluis; E C van Reede; M Boer
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

9.  Antibody-independent interactions of fibronectin, C1q, and human neutrophils with Treponema pallidum.

Authors:  R E Baughn
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

10.  Serological characterization and gene localization of an Escherichia coli-expressed 37-kilodalton Treponema pallidum antigen.

Authors:  G C Rodgers; W J Laird; S R Coates; D H Mack; M Huston; J J Sninsky
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.